Squamous Cell Carcinoma of the Hypopharynx Clinical Trials

8 clinical trials for Squamous Cell Carcinoma of the Hypopharynx across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel — RECRUITING
• De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck — RECRUITING · PHASE2
• Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome — RECRUITING
• Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — COMPLETED · PHASE1
• Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC — WITHDRAWN · PHASE2
• Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial — NOT_YET_RECRUITING · PHASE2
• A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer — COMPLETED · NA
• Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) — COMPLETED · PHASE2

Refine this search